FDA 483 - AML Riverside, LLC - April 03, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
AML Riverside, LLC, a drug manufacturer in Fort Dodge, IA, received a Form 483 citing significant deficiencies during an FDA inspection. The observations included a lack of strict control over drug product labeling, failures within the quality control unit regarding overdue CAPA items and product trending, and non-adherence to established laboratory control mechanisms for investigative testing. These issues indicate a need for improved adherence to Good Manufacturing Practices.
ID · 4f222a39-4e05-4093-97e2-ffa41e798a4a